Etanercept for Wegener's Granulomatosis - Contacts and Locations

Etanercept for Wegener's Granulomatosis

This study has been completed.

Study NCT00005007. Last updated on December 19, 2007. Information provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005007

Locations


United States, California
	University of California, San Francisco
	San Francisco, California, United States, 94143

United States, Maryland
	Johns Hopkins University
	Baltimore, Maryland, United States, 21224

United States, Massachusetts
	Boston University
	Boston, Massachusetts, United States, 02118

United States, Michigan
	University of Michigan
	Ann Arbor, Michigan, United States, 48109

United States, Minnesota
	Mayo Clinic
	Rochester, Minnesota, United States, 55905

United States, New York
	Beth Israel Medical Center
	New York, New York, United States, 10128

United States, North Carolina
	Duke University
	Durham, North Carolina, United States, 27710

United States, Ohio
	Cleveland Clinic Foundation
	Cleveland, Ohio, United States, 44195

Sponsors and Collaborators

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

FDA Office of Orphan Products Development

Investigators


Principal Investigator:	John H. Stone, MD, MPH	Johns Hopkins University